Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration

OBJECTIVES: To evaluate the outcomes of delayed intravitreal injections (IVIs) caused by the outbreak of coronavirus disease 2019 (COVID-19), in patients with neovascular age-related macular degeneration (nAMD). METHODS: nAMD patients with scheduled IVIs between March 1(st) and April 30(th), 2020 we...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassisi, Marco, Pozzo Giuffrida, Francesco, Milella, Paolo, Ganci, Simone, Aretti, Andrea, Mainetti, Claudia, Dell’Arti, Laura, Mapelli, Chiara, Viola, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107548/
https://www.ncbi.nlm.nih.gov/pubmed/37069537
http://dx.doi.org/10.1186/s12886-023-02864-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107548/
https://www.ncbi.nlm.nih.gov/pubmed/37069537
http://dx.doi.org/10.1186/s12886-023-02864-x

Ejemplares similares